Delivery Order SPE2DB24D1205-SPE2DB25FDACM
Award Date 9/4/25
Potential Completion Date 9/25/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $23,255.50 delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on August 18, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's location in Conshohocken, Pennsylvania. LEQVIO is an injectable cardiovascular medication used to lower LDL cholesterol levels, reflecting the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,976.65 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, competitively awarded contract—with no set-aside designation—calls for delivery of the pharmaceutical product to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. LEQVIO is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $34,883.25. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. LEQVIO is a prescription pharmaceutical product used in cardiovascular treatment, reflecting the Defense Logistics Agency...
- The Defense Logistics Agency awarded a $9.3K delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on September 26, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LEQVIO is a prescription medication used to lower cholesterol levels, and this delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.55 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on June 26, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,953.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $4,901.54. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,255.50 to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 14, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...